Some thoughts:
PYC's SP is in a positive trendline (PEACEAKKI, thanks) and the motivations for director's selling seems pretty straightforward, (thanks Andrew65).
With a recent low of around 5 cents, there are many recent buyers with a good reason to sell at over 7 cents. Just as these same folk see 8+ as too much of a leap to average up with.
So, for me, the recent (pre-good news) low of 5 cents is the real 'culprit' here, if there is one to name!
PYC has increased over 50% in 5 months and presents an excellent chart.
I see the determined retiree's selling as a great opportunity to buy at a discounted price to the actual de-risked new prospects of this company!
By de-risked I mean:
1. Frost and Sullivan Award,(Jan 2011)
2. Smallest MC in top 10 Bio-tech of the Year, (Jan 2011)
3. Funding finalised for re-vamped cash producing Perth lab, (Dec, 2010)
4. Big Pharma deals more transparently profitable for PYC short-term (various sources) 2011.
5. Big Pharma offer multiple (hundreds) of possible company-maker royalty generating compounds,
6. PYC established in industry in 'new-age' drug delivery (transport peptides for anti-biotic and anti-cancer drugs) research.
7. PYC deal with German pharma XL-protein GmbH for extending multiple drug classes 'half-life' (lower doses and lower side-effects) (Jan, 2011)
8. Astute management driving extremely lucrative contracts from a position of strength, in a unique biotech area where it's a 'seller's market'.
9. An established and increasing trend towards multiple contracts offering a cash-flow positive balance sheet for the foreseeable future.
10. The likelihood of multiple SP bumping good news over 11/12 and further international marketing magic yet to be exploited by recent (Dec/Jan) milestone announcements.
11. Multi-bagger takeover potential within 3 years.
Therefore, I see the 8 cent ceiling as a great opportunity to astutely accumulate at this time at these levels.
For these reasons, I believe all is on track for my money; although this stock is not for short-termies in the short term. Also, it's not for the impatient, or those with less than a 6 month investment churn strategy
The current eager selling around 7.7 - 8.3 cents represents a fantastic buying opportunity for a relatively ignored stock, still just below the horizon of the many would-be loyal fans.
A great buying opportunity for the confident, in a relatively ignored rising star IMHO
Good Luck to all: side-line sitters, holders, sellers and bottom drawers!
Positivity drives dreams.
PatrickM
- Forums
- ASX - By Stock
- PYC
- rising star
rising star
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.010(7.69%) |
Mkt cap ! $653.2M |
Open | High | Low | Value | Volume |
14.0¢ | 14.5¢ | 13.0¢ | $1.446M | 10.38M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 252759 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 113762 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 252759 | 0.135 |
10 | 902883 | 0.130 |
7 | 553701 | 0.125 |
8 | 594999 | 0.120 |
3 | 205000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 113762 | 2 |
0.145 | 1772492 | 12 |
0.150 | 995500 | 12 |
0.160 | 29077 | 2 |
0.170 | 103000 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online